JP2025118688A5 - - Google Patents
Info
- Publication number
- JP2025118688A5 JP2025118688A5 JP2025069830A JP2025069830A JP2025118688A5 JP 2025118688 A5 JP2025118688 A5 JP 2025118688A5 JP 2025069830 A JP2025069830 A JP 2025069830A JP 2025069830 A JP2025069830 A JP 2025069830A JP 2025118688 A5 JP2025118688 A5 JP 2025118688A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antigen
- humanized antibody
- binding fragment
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962912534P | 2019-10-08 | 2019-10-08 | |
| US62/912,534 | 2019-10-08 | ||
| JP2022518775A JP7754506B2 (ja) | 2019-10-08 | 2020-10-07 | ポリオウイルス受容体（ｐｖｒ）に対する抗体およびその使用 |
| PCT/IL2020/051082 WO2021070181A1 (en) | 2019-10-08 | 2020-10-07 | Antibodies against the poliovirus receptor (pvr) and uses thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022518775A Division JP7754506B2 (ja) | 2019-10-08 | 2020-10-07 | ポリオウイルス受容体（ｐｖｒ）に対する抗体およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025118688A JP2025118688A (ja) | 2025-08-13 |
| JP2025118688A5 true JP2025118688A5 (enExample) | 2025-12-05 |
Family
ID=73038283
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022518775A Active JP7754506B2 (ja) | 2019-10-08 | 2020-10-07 | ポリオウイルス受容体（ｐｖｒ）に対する抗体およびその使用 |
| JP2025069830A Pending JP2025118688A (ja) | 2019-10-08 | 2025-04-21 | ポリオウイルス受容体（ｐｖｒ）に対する抗体およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022518775A Active JP7754506B2 (ja) | 2019-10-08 | 2020-10-07 | ポリオウイルス受容体（ｐｖｒ）に対する抗体およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220372161A1 (enExample) |
| EP (1) | EP4041392A1 (enExample) |
| JP (2) | JP7754506B2 (enExample) |
| KR (1) | KR20220082007A (enExample) |
| CN (2) | CN114502595B (enExample) |
| AU (1) | AU2020363041B2 (enExample) |
| BR (1) | BR112022006620A2 (enExample) |
| CA (1) | CA3156983A1 (enExample) |
| IL (1) | IL291540A (enExample) |
| MX (1) | MX2022004194A (enExample) |
| WO (1) | WO2021070181A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2024011278A (es) | 2022-03-15 | 2024-09-25 | Compugen Ltd | Anticuerpos antagonistas de il-18bp y su uso en monoterapia y terapia de combinacion en el tratamiento del cancer. |
| KR102615797B1 (ko) * | 2022-04-28 | 2023-12-19 | 가톨릭대학교 산학협력단 | T 세포에 의한 교모세포종 치료 효과의 유효성 예측 방법 |
| KR20250058747A (ko) | 2022-09-04 | 2025-04-30 | 넥틴 테라퓨틱스 리미티드 | 인간화 항 pvr 항체의 약물 접합체 |
| TW202515608A (zh) | 2023-06-26 | 2025-04-16 | 以色列商坎布根有限公司 | Ｉｌ—１８ｂｐ拮抗抗體及其於癌症治療之單一療法及組合療法的用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| DE3883899T3 (de) | 1987-03-18 | 1999-04-22 | Sb2, Inc., Danville, Calif. | Geänderte antikörper. |
| EP0940468A1 (en) | 1991-06-14 | 1999-09-08 | Genentech, Inc. | Humanized antibody variable domain |
| WO1994029351A2 (en) | 1993-06-16 | 1994-12-22 | Celltech Limited | Antibodies |
| KR101077001B1 (ko) | 1999-01-15 | 2011-10-26 | 제넨테크, 인크. | 효과기 기능이 변화된 폴리펩티드 변이체 |
| US7361740B2 (en) | 2002-10-15 | 2008-04-22 | Pdl Biopharma, Inc. | Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| EP1481993A1 (en) | 2003-05-28 | 2004-12-01 | Xerion Pharmaceuticals AG | Modulation of the poliovirus receptor function |
| JP6296650B2 (ja) | 2013-03-13 | 2018-03-20 | 国立大学法人 筑波大学 | 免疫疾患に対する医薬組成物 |
| JP6180663B2 (ja) * | 2014-12-23 | 2017-08-16 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | Ｔｉｇｉｔに対する抗体 |
| JP5995117B2 (ja) | 2015-01-26 | 2016-09-21 | 国立大学法人 筑波大学 | 可溶型ｃｄ１５５タンパク質を用いた癌の検出方法 |
| US20180251548A1 (en) | 2015-09-14 | 2018-09-06 | Compass Therapeutics Llc | Compositions and methods for treating cancer via antagonism of the cd155/tigit pathway and tgf-beta |
| EP4043492A1 (en) * | 2016-03-01 | 2022-08-17 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Antibodies specific to human poliovirus receptor (pvr) |
-
2020
- 2020-10-07 KR KR1020227014889A patent/KR20220082007A/ko active Pending
- 2020-10-07 CA CA3156983A patent/CA3156983A1/en active Pending
- 2020-10-07 EP EP20799841.0A patent/EP4041392A1/en active Pending
- 2020-10-07 AU AU2020363041A patent/AU2020363041B2/en active Active
- 2020-10-07 BR BR112022006620A patent/BR112022006620A2/pt unknown
- 2020-10-07 CN CN202080071097.9A patent/CN114502595B/zh active Active
- 2020-10-07 JP JP2022518775A patent/JP7754506B2/ja active Active
- 2020-10-07 CN CN202510568361.4A patent/CN120424218A/zh active Pending
- 2020-10-07 MX MX2022004194A patent/MX2022004194A/es unknown
- 2020-10-07 US US17/764,373 patent/US20220372161A1/en active Pending
- 2020-10-07 WO PCT/IL2020/051082 patent/WO2021070181A1/en not_active Ceased
-
2022
- 2022-03-21 IL IL291540A patent/IL291540A/en unknown
-
2025
- 2025-04-21 JP JP2025069830A patent/JP2025118688A/ja active Pending